Trinity Biotech plc (NASDAQ:TRIB) Given Consensus Recommendation of "Hold" by Brokerages

Trinity Biotech plc (NASDAQ:TRIB) Given Consensus Recommendation of "Hold" by Brokerages

Trinity Biotech plc has been given a consensus rating of "Hold" by the six research firms that are presently covering the firm. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating on the company.

from Biotech News